Merck and Mayo Clinic Announce AI-Driven Drug Discovery Collaboration Leveraging Multimodal Clinical Data
Merck partners with Mayo Clinic to leverage AI, advanced analytics, and the Mayo Clinic Platform's genomic and clinical data for drug discovery and precision medicine. The collaboration initially targets inflammatory bowel disease, atopic dermatitis, and multiple sclerosis.
